Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
WallStPal · PDF guide
NAMS Insider Trading and Fund Holdings (NewAmsterdam Pharma Co N.V.) · https://wallstpal.com/stock/nams/ · saved 2026-10-28

About this page

Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.

How to read it

Form 4
The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
Buy (P) and Sell (S)
Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
Value
Shares times price, as reported on the filing.
10b5-1
A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
Late filing
A Form 4 filed more than two business days after the trade.
Vs. S&P 500
How the stock did after the trade minus how the overall market did in the same weeks.

A real example

In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.

Explain it like I'm 13

If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.

Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.

Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
StockCIK 1936258

NewAmsterdam Pharma Co N.V. (NAMS): Insider Trades and Fund Holdings

In the past 12 months, NewAmsterdam Pharma Co N.V. insiders reported 1 open-market purchase worth $227K and 5 sales worth $9.06M; 4 of the sales were reported as made under a 10b5-1 trading plan.

1Insider buys, 12 months
$227KBought by insiders, 12 months
$9.06MSold by insiders, 12 months
2Tracked funds holding

Timeline: news and trades

Company filings (8-K), insider trades, notices of planned sales (Form 144), Congress trades and fund moves in the past year, newest first.

  1. Sep 30, 2026Insider saleChief Scientific Officer Johannes Jacob Pieter Kastelein sold $1.3 million under a 10b5-1 plan
  2. Sep 14, 2026Insider buyCEO Michael H. Davidson bought $226,500
  3. Sep 4, 2026Insider saleDirector John W. Smither sold $40,512
  4. Aug 25, 2026Planned saleKastelein Johannes Jacob Pieter (affiliate) filed notice to sell about $7 million around Aug 25, 2026
  5. Aug 24, 2026Insider saleChief Scientific Officer Johannes Jacob Pieter Kastelein sold $3.4 million under a 10b5-1 plan
  6. Aug 24, 2026Planned saleKastelein Johannes Jacob Pieter (affiliate) filed notice to sell about $3.5 million around Aug 24, 2026
  7. Jul 20, 2026Insider saleCAO Louise Frederika Kooij sold $3.2 million under a 10b5-1 plan
  8. Jun 22, 2026Insider saleCAO Louise Frederika Kooij sold $1.2 million under a 10b5-1 plan

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 2, 2026.

Recent NAMS insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueScoreHoldingFiling
Oct 2Sep 30Johannes Jacob Pieter KasteleinChief Scientific OfficerChief Scientific Officer (ind.)▼ SELL10b5-150,24625.03$1.26M−42%Form 4 ↗
Sep 15Sep 14Michael H. DavidsonCEOCEO▲ BUY10,00022.65$227K42+1.3%Form 4 ↗
Sep 9Sep 4John W. SmitherDirectorDirector▼ SELL1,60025.32$41K−15%Form 4 ↗
Aug 25Aug 24Johannes Jacob Pieter KasteleinChief Scientific OfficerChief Scientific Officer (ind.)▼ SELL10b5-1125,00026.91$3.36M−64%Form 4 ↗
Jul 22Jul 20Louise Frederika KooijCAOCAO▼ SELL10b5-1105,00030.34$3.19M−81%Form 4 ↗
Jun 24Jun 22Louise Frederika KooijCAOCAO▼ SELL10b5-140,00030.20$1.21M−62%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

InsiderRoleBuysBoughtSellsSoldLatest
Johannes Jacob Pieter KasteleinChief Scientific Officer0$02$4.62MOct 2, 2026
Michael H. DavidsonCEO1$227K0$0Sep 15, 2026
John W. SmitherDirector0$01$41KSep 9, 2026
Louise Frederika KooijCAO0$02$4.39MJul 22, 2026

Buybacks and executive pay

YearCEO pay reportedCEO pay "actually paid"Value of $100 invested
2025$13.6M$30.5Mn/a
2024$6.47M$49.5Mn/a
2023$5.81M$4.72Mn/a

From the company's XBRL data filed with the SEC. "Actually paid" is the SEC's pay-versus-performance measure, which counts changes in the value of stock awards. "Value of $100 invested" is the company's cumulative shareholder return as reported, usually measured from five years earlier. See all buybacks and CEO pay across companies.

Strongest purchase, 12 months

42 Michael H. Davidson (CEO), 2026-09-14. What the score means

Filing quality

A All 6 insider trades reported on time. How it is graded

Tracked funds that report NAMS

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

FundQuarterSharesValue% of portfolioChange
Viking Global InvestorsQ2 20264,203,567$142.5M0.41%No change
Duquesne Family OfficeQ2 20263,070,146$104K2.39%No change
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →